Pfizer Ltd
NSE:PFIZER
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4 031.9
6 318.3
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one PFIZER stock under the Base Case scenario is 2 634.79 INR. Compared to the current market price of 5 263.5 INR, Pfizer Ltd is Overvalued by 50%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Pfizer Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for PFIZER cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Pfizer Ltd
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Pfizer Ltd
Balance Sheet Decomposition
Pfizer Ltd
Current Assets | 30.5B |
Cash & Short-Term Investments | 23B |
Receivables | 2.3B |
Other Current Assets | 5.2B |
Non-Current Assets | 14B |
Long-Term Investments | 121.3m |
PP&E | 1.4B |
Intangibles | 5.6B |
Other Non-Current Assets | 7B |
Current Liabilities | 6B |
Accounts Payable | 1.8B |
Short-Term Debt | 25m |
Other Current Liabilities | 4.2B |
Non-Current Liabilities | 1B |
Long-Term Debt | 377.6m |
Other Non-Current Liabilities | 653.1m |
Earnings Waterfall
Pfizer Ltd
Revenue
|
22.4B
INR
|
Cost of Revenue
|
-7.8B
INR
|
Gross Profit
|
14.5B
INR
|
Operating Expenses
|
-8.1B
INR
|
Operating Income
|
6.5B
INR
|
Other Expenses
|
-299.3m
INR
|
Net Income
|
6.2B
INR
|
Free Cash Flow Analysis
Pfizer Ltd
INR | |
Free Cash Flow | INR |
PFIZER Profitability Score
Profitability Due Diligence
Pfizer Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
Score
Pfizer Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
PFIZER Solvency Score
Solvency Due Diligence
Pfizer Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Score
Pfizer Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PFIZER Price Targets Summary
Pfizer Ltd
According to Wall Street analysts, the average 1-year price target for PFIZER is 6 409 INR with a low forecast of 5 353 INR and a high forecast of 7 533.75 INR.
Dividends
Current shareholder yield for PFIZER is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
PFIZER Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Pfizer Ltd. engages in the business of manufacturing, marketing, trading, import and export of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 2,285 full-time employees. The firm has a portfolio of approximately 150 products across over 15 therapeutic areas. The firm is engaged in manufacturing, marketing, trading and exporting pharmaceutical products. The firm offers a range of products for anti-diabetic, anti-infectives, cardiovascular, dermatology, erectile dysfunction, gastrointestinal (GI), multivitamins, neurology, pain/fever/inflammation and autoimmune disorders, among others. Its products include Trulimax, Vibazime DT, Viagra, Daxid, Tricorex, Mucaine, Diamox, Hetrazan, Enbrel, Ativan, Pacitane, Folvite Tablets, Autrin Capsules, Prevenar 13, Wysolone, Loette, Ovral G, Ovral L, Premarin tablets, Premarin Vaginal Cream, Zosyn, Wymox, Tygacil, Cynomycin, Targit, Cyklokapron and Magnamycin. The firm has its own manufacturing facility at Thane and Goa. The firm has various independent contract/third party manufacturers based across the country.
Contact
IPO
Employees
Officers
The intrinsic value of one PFIZER stock under the Base Case scenario is 2 634.79 INR.
Compared to the current market price of 5 263.5 INR, Pfizer Ltd is Overvalued by 50%.